Compound ID | 823
Class: Oxazolidinone
| Spectrum of activity: | Gram-negative |
| Institute where first reported: | Versicor Inc. (Pfizer, USA) |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Pfizer had linezolid. None of these had advantages (LS) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/485764 |
| Citation: |